Ideally, Medical Affairs organizational design should be assessed early on in Medical Affairs functional development to identify...

The past year has been one of ups and downs for the biopharma industry and workforce dynamics have been significantly impacted....

In the fast-paced world of life sciences, especially in early-stage cell and gene therapy companies, a tug-of-war exists between...

One of the most pressing challenges pharmaceutical companies face is balancing the need to invest in critical capabilities like...

Consider, for a moment, the measurement of impact that commercial activities and medical affairs activities in a life science...

One of the key learnings from successful product launches is that successful launch teams relentlessly measure performance and...

Think your Biopharma startup is “too small” for cybersecurity risk? We see it all the time. Read these real cybersecurity breach...